HSCA Comments to the Senate Committee on Homeland Security and Governmental Affairs (HSGAC)’s Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group...
Learn MoreHealthcare Supply Chain Leadership Summit Materials
This content is password protected. To view it please enter your password below:
Password:
Learn MoreHSCA NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT OF PHARMACY TERRI LYLE WILSON TO BOARD OF DIRECTORS
Washington, DC (September 20, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading...
Learn MoreHSCA Comments to Energy & Commerce Committee’s Stop Drug Shortages Act Discussion Draft
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group...
Learn MoreHSCA Response to Congressional Drug Shortages Request for Information (RFI)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group...
Learn MoreHSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S....
Learn MoreHSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing...
Learn MoreHSCA ANNOUNCES INAUGURAL HEALTHCARE SUPPLY CHAIN LEADERSHIP SUMMIT
Washington, DC (May 9, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare...
Learn More